Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: Double-blind, randomized, active-controlled multicenter phase III clinical trial

References

• Grohskopf LA, Olsen SJ, Sokolow LZ, Bresee JS, Cox NJ, Broder KR, Karron RA, Walter EB; Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep 2014; 63:691-7; PMID:25121712
   PubMed Web of Science ®Google Scholar
• Jo DS, Kim JH, Choi EH, Park SE, Kim YJ, Kim YK, Lee J, Eun BW, Lee SY, Lee H, et al. Recommended immunization schedule for children and adolescents: the Korean Pediatric Society, 2013. Korean J Pediatr 2013; 56:231-4; PMID:23807888; http://dx.doi.org/10.3345/kjp.2013.56.6.231
   PubMedGoogle Scholar
• Dawood FS, Fiore A, Kamimoto L, Bramley A, Reingold A, Gershman K, Meek J, Hadler J, Arnold KE, Ryan P, et al. Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. J Pediatr 2010; 157:808-14; PMID:20580018; http://dx.doi.org/10.1016/j.jpeds.2010.05.012
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Silvennoinen H, Peltola V, Ziegler T, Vainionpaa R, Vuorinen T, Kainulainen L, Puhakka T, Jartti T, Toikka P, et al. Burden of influenza in children in the community. J Infect Dis 2004; 190:1369-73; PMID:15378427; http://dx.doi.org/10.1086/424527
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Jr., Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342:225-31; PMID:10648763; http://dx.doi.org/10.1056/NEJM200001273420401
   PubMed Web of Science ®Google Scholar
• O'Brien MA, Uyeki TM, Shay DK, Thompson WW, Kleinman K, McAdam A, Yu XJ, Platt R, Lieu TA. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 2004; 113:585-93; PMID:14993554; http://dx.doi.org/10.1542/peds.113.3.585
   PubMed Web of Science ®Google Scholar
• Proff R, Gershman K, Lezotte D, Nyquist AC. Case-based surveillance of influenza hospitalizations during 2004-2008, Colorado, USA. Emerg Infect Dis 2009; 15:892-8; PMID:19523287; http://dx.doi.org/10.3201/eid1506.081645
   PubMedGoogle Scholar
• Weigl JA, Puppe W, Schmitt HJ. The incidence of influenza-associated hospitalizations in children in Germany. Epidemiol Infect 2002; 129:525-33; PMID:12558335; http://dx.doi.org/10.1017/S0950268802007707
   PubMed Web of Science ®Google Scholar
• Longini IM, Jr., Koopman JS, Monto AS, Fox JP. Estimating household and community transmission parameters for influenza. Am J Epidemiol 1982; 115:736-51; PMID:7081204
   PubMed Web of Science ®Google Scholar
• Hadler JL, Yousey-Hindes K, Kudish K, Kennedy ED, Sacco V, Cartter ML; Centers for Disease Control and Prevention (CDC). Impact of requiring influenza vaccination for children in licensed child care or preschool programs - Connecticut, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep 2014; 63:181-5; PMID:24598593
   PubMed Web of Science ®Google Scholar
• Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001; 344:889-96; PMID:11259722; http://dx.doi.org/10.1056/NEJM200103223441204
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration Center for Biologics Evaluation and Research. Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines [Internet]. Rockville, MD: Taylor & Francis; 2007 May [cited 2014 Oct 20]. 16 p. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm091990.pdf
   Google Scholar
• Bae EY, Choi UY, Kwon HJ, Jeong DC, Rhim JW, Ma SH, Lee KI, Kang JH. Immunogenicity and safety of an inactivated trivalent split influenza virus vaccine in young children with recurrent wheezing. Clin Vaccine Immunol 2013; 20:811-7; PMID:23536692; http://dx.doi.org/10.1128/CVI.00008-13
   PubMedGoogle Scholar
• Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Pediatrics 2005; 115:1039-47; PMID:15805382; http://dx.doi.org/10.1542/peds.2004-2373
   PubMed Web of Science ®Google Scholar
• Gonzalez M, Pirez MC, Ward E, Dibarboure H, Garcia A, Picolet H. Safety and immunogenicity of a paediatric presentation of an influenza vaccine. Arch Dis Child 2000; 83:488-91; PMID:11087282; http://dx.doi.org/10.1136/adc.83.6.488
   PubMed Web of Science ®Google Scholar
• Groothuis JR, Levin MJ, Rabalais GP, Meiklejohn G, Lauer BA. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics 1991; 87:823-8; PMID:2034485
   PubMed Web of Science ®Google Scholar
• Kang JH, Oh CE, Lee J, Lee SY, Cha SH, Kim DS, Kim HH, Lee JH, Kim JT, Ma SH, et al. Safety and immunogenicity of a new trivalent inactivated split-virus influenza vaccine in healthy Korean children: a randomized, double-blinded, active-controlled, phase III study. J Korean Med Sci 2011; 26:1421-7; PMID:22065897; http://dx.doi.org/10.3346/jkms.2011.26.11.1421
   PubMedGoogle Scholar
• Kanra G, Marchisio P, Feiterna-Sperling C, Gaedicke G, Lazar H, Durrer P, Kürsteiner O, Herzog C, Kara A, Principi N. Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children. Pediatr Infect Dis J 2004; 23:300-6; PMID:15071282; http://dx.doi.org/10.1097/00006454-200404000-00005
   PubMed Web of Science ®Google Scholar
• Kim YK, Eun BW, Kim NH, Kang EK, Lee BS, Kim DH, Lim JS. Comparison of immunogenicity and reactogenicity of split versus subunit influenza vaccine in Korean children aged 6-35 months. Scand J Infect Dis 2013; 45:460-8; PMID:23294036; http://dx.doi.org/10.3109/00365548.2012.755267
   PubMed Web of Science ®Google Scholar
• Walter EB, Rajagopal S, Zhu Y, Neuzil KM, Fairchok MP, Englund JA. Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally? Vaccine 2010; 28:4376-83; PMID:20447477; http://dx.doi.org/10.1016/j.vaccine.2010.04.058
   PubMed Web of Science ®Google Scholar
• Seidman JC, Richard SA, Viboud C, Miller MA. Quantitative review of antibody response to inactivated seasonal influenza vaccines. Influenza Other Respir Viruses 2012; 6:52-62; PMID:21668661; http://dx.doi.org/10.1111/j.1750-2659.2011.00268.x
   PubMed Web of Science ®Google Scholar
• Langley JM, Vanderkooi OG, Garfield HA, Hebert J, Chandrasekaran V, Jain VK, Fries L. Immunogenicity and safety of 2 dose levels of a thimerosal-free trivalent seasonal influenza vaccine in children aged 6-35 months: a randomized, controlled trial. J Pediatr Infect Dis Soc 2012; 1:55-63; PMID:23687572; http://dx.doi.org/10.1093/jpids/pis012
   PubMedGoogle Scholar
• Yang P, Thompson MG, Ma C, Shi W, Wu S, Zhang D, Wang Q. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China. Vaccine 2014; 32:5285-9; PMID:25092635; http://dx.doi.org/10.1016/j.vaccine.2014.07.083
   PubMed Web of Science ®Google Scholar
• Ahout I, Ferwerda G, de Groot R. Influenza vaccination in kids, are you kidding me? J Infect 2014; 68(Suppl 1):S100-7; PMID:24206897; http://dx.doi.org/10.1016/j.jinf.2013.09.019
   PubMedGoogle Scholar
• Heinonen S, Silvennoinen H, Lehtinen P, Vainionpaa R, Ziegler T, Heikkinen T. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infect Dis 2011; 11:23-9; PMID:21106443; http://dx.doi.org/10.1016/S1473-3099(10)70255-3
   PubMed Web of Science ®Google Scholar
• Blyth CC, Jacoby P, Effler PV, Kelly H, Smith DW, Robins C, Willis GA, Levy A, Keil AD, Richmond PC; WAIVE Study Team. Effectiveness of trivalent flu vaccine in healthy young children. Pediatrics 2014; 133:e1218-25; PMID:24753525; http://dx.doi.org/10.1542/peds.2013-3707
   PubMedGoogle Scholar
• DiazGranados CA, Denis M, Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 2012; 31:49-57; PMID:23142300; http://dx.doi.org/10.1016/j.vaccine.2012.10.084
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, Dunn J, DeStefano F, Shay D. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 2006; 194:1032-9; PMID:16991077; http://dx.doi.org/10.1086/507309
   PubMed Web of Science ®Google Scholar
• Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 1990; 175:59-68; PMID:2309452; http://dx.doi.org/10.1016/0042-6822(90)90186-U
   PubMed Web of Science ®Google Scholar
• Roy T, Agrawal AS, Mukherjee A, Mishra AC, Chadha MS, Kaur H, Chawla-Sarkar M. Surveillance and molecular characterization of human influenza B viruses during 2006-2010 revealed co-circulation of Yamagata-like and Victoria-like strains in eastern India. Infect Genet Evol 2011; 11:1595-601; PMID:21708292; http://dx.doi.org/10.1016/j.meegid.2011.05.022
   PubMedGoogle Scholar
• Block SL, Falloon J, Hirschfield JA, Krilov LR, Dubovsky F, Yi T, Belshe RB. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children. Pediatr Infect Dis J 2012; 31:745-51; PMID:22466322; http://dx.doi.org/10.1097/INF.0b013e31825687b0
   PubMed Web of Science ®Google Scholar
• Langley JM, Carmona Martinez A, Chatterjee A, Halperin SA, McNeil S, Reisinger KS, Aggarwal N, Huang LM, Peng CT, Garcia-Sicilia J, et al. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children. J Infect Dis 2013; 208:544-53; PMID:23847058; http://dx.doi.org/10.1093/infdis/jit263
   PubMed Web of Science ®Google Scholar
• Greenberg DP, Robertson CA, Landolfi VA, Bhaumik A, Senders SD, Decker MD. Safety and immunogenicity of an inactivated quadrivalent influenza vaccine in children 6 months through 8 years of age. Pediatr Infect Dis J 2014; 33:630-6; PMID:24445833; http://dx.doi.org/10.1097/INF.0000000000000254
   PubMed Web of Science ®Google Scholar
• Song JY, Cheong HJ, Hwang IS, Choi WS, Jo YM, Park DW, Cho GJ, Hwang TG, Kim WJ. Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence. Vaccine 2010; 28:3929-35; PMID:20394719; http://dx.doi.org/10.1016/j.vaccine.2010.03.067
   PubMed Web of Science ®Google Scholar